Cladribine, Cytarabine and Idarubicin in Patients With Relapsed Acute Myelocytic Leukemia (AML)

Clinical trial NCT00126321 · UNKNOWN

Trial details

NCT number: NCT00126321
Sponsor: University Hospital, Bonn
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia, Myelocytic, Acute

Start date: 2004-11-01
Primary completion: 2010-11-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.